Contact your GP, diabetes specialist nurse, or NHS 111 if: Headaches are persistent, worsening, or significantly impacting daily activities despite simple management measures You experience frequent hypoglycaemic episodes (blood glucose below 4 mmol/L) [31] [32] You have signs of dehydration such as reduced urine output, excessive thirst, or dizziness when standing Side effects are affecting medication adherence or quality of life You develop new or unusual symptoms that concern you Headaches follow a different pattern from any pre-existing headache disorder Healthcare professionals can assess whether headaches are likely related to GLP-1 therapy or require investigation for alternative causes
Tools like electronic PA integration offer hope to shrink delays over time, but cannot alone solve coverage denials
Crucially, beyond its potential therapeutic application to prevent post-discontinuation weight regain, fecal microbiota transplantation (FMT) must be positioned as an indispensable mechanistic research tool
Trulicity (dulaglutide) is a prescription antidiabetic injectable medication that belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1).GLP-1 receptor agonists have been shown to lower hemoglobin A1C, an indicator of long-term blood glucose control, by up to 1.6%
